Sfoglia per Autore
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment
2023-01-01 Boumya, Sara; Fallarini, Silvia; Siragusa, Sonia; Petrarolo, Giovanni; Aprile, Silvio; Audrito, Valentina; La Motta, Concettina; Garavaglia, Silvia; Moro, Laura; Pinton, Giulia
A novel ABHD5 mutation in two Chanarin Dorfman siblings with severe and heterogeneous clinical phenotype
2023-01-01 Elsayed, S. M.; Torre, E.; Tavian, D.; Moro, L.; Angelini, C.; Abdel Ghaffar, T. Y.; Zalata, K.; Fahmy, E. E.; Missaglia, S.
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
2023-01-01 Al Khatib, M. H. D. O.; Pinton, G.; Moro, L.; Porta, C.
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment
2022-01-01 Sculco, M.; La Vecchia, M.; Aspesi, A.; Pinton, G.; Clavenna, M. G.; Casalone, E.; Allione, A.; Grosso, F.; Libener, R.; Muzio, A.; Rena, O.; Baietto, G.; Parini, S.; Boldorini, R.; Giachino, D.; Papotti, M.; Scagliotti, G. V.; Migliore, E.; Mirabelli, D.; Moro, L.; Magnani, C.; Ferrante, D.; Matullo, G.; Dianzani, I.
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake
2022-01-01 Gabano, E.; Zanellato, I.; Pinton, G.; Moro, L.; Ravera, M.; Osella, D.
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review
2021-01-01 Pinton, Giulia; Manzotti, Beatrice; Balzano, Cecilia; Moro, Laura
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines
2021-01-01 Gabano, E.; Pinton, G.; Balzano, C.; Boumya, S.; Osella, D.; Moro, L.; Ravera, M.
CDKN2A determines mesothelioma cell fate to EZH2 inhibition
2021-01-01 Pinton, Giulia; Wang, Zhuo; Balzano, Cecilia; Missaglia, Sara; Tavian, Daniela; Boldorini, Renzo; A Fennell, Dean; Griffin, Martin; Moro, Laura
Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids
2021-01-01 Mola, S.; Pinton, G.; Erreni, M.; Corazzari, M.; Andrea, M. D.; Grolla, A. A.; Martini, V.; Moro, L.; Porta, C.
Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cells
2020-01-01 Pinton, G.; Ferraro, A.; Balma, M.; Moro, L.
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells
2019-01-01 Soluri, Angela Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Moro, Laura; Forestieri, Gabriela; Autiero, Ida; Cavallo, Luigi; Oliva, Romina; Griffin, Martin; Wang, Zhuo; Santoro, Claudio Ventura; Sblattero, Daniele
A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings
2019-01-01 Eskiocak, Ali Haydar; Missaglia, Sara; Moro, Laura; Durdu, Murat; Tavian, Daniela
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition
2019-01-01 Ayinde, O.; Wang, Z.; Pinton, G.; Moro, L.; Griffin, M.
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality
2018-01-01 Pinton, Giulia; Nilsson, Stefan; Moro, Laura
Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency
2018-01-01 Missaglia, Sara; Tavian, Daniela; Moro, Laura; Angelini, Corrado
Clinical and genetic characterization of a Chanarin Dorfman Syndrome patient born to diseased parents
2018-01-01 Durdu, M; Missaglia, S; Moro, L; Tavian, D
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
2017-01-01 Zonca, Sara; Pinton, Giulia; Wang, Z; Soluri, Mf; Tavian, D; Griffin, M; Sblattero, D; Moro, Laura
Expression and therapeutic significance of estrogen receptor beta (ERβ) in malignant pleural mesothelioma
2017-01-01 Pinton, Giulia; Moro, Laura
Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement
2017-01-01 Missaglia, Sara; Maggi, Lorenzo; Mora, Marina; Gibertini, Sara; Blasevich, Flavia; Agostoni, Piergiuseppe; Moro, Laura; Cassandrini, Denise; Santorelli, Filippo Maria; Gerevini, Simonetta; Tavian, Daniela
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.
2016-01-01 Pinton, Giulia; Zonca, Sara; Manente, Arcangela Gabriella; Cavaletto, Maria; Borroni, E; Daga, A; Jithesh, Pv; Fennell, D; Nilsson, S; Moro, Laura
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment | 1-gen-2023 | Boumya, Sara; Fallarini, Silvia; Siragusa, Sonia; Petrarolo, Giovanni; Aprile, Silvio; Audrito, Valentina; La Motta, Concettina; Garavaglia, Silvia; Moro, Laura; Pinton, Giulia | |
| A novel ABHD5 mutation in two Chanarin Dorfman siblings with severe and heterogeneous clinical phenotype | 1-gen-2023 | Elsayed, S. M.; Torre, E.; Tavian, D.; Moro, L.; Angelini, C.; Abdel Ghaffar, T. Y.; Zalata, K.; Fahmy, E. E.; Missaglia, S. | |
| Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma | 1-gen-2023 | Al Khatib, M. H. D. O.; Pinton, G.; Moro, L.; Porta, C. | |
| Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment | 1-gen-2022 | Sculco, M.; La Vecchia, M.; Aspesi, A.; Pinton, G.; Clavenna, M. G.; Casalone, E.; Allione, A.; Grosso, F.; Libener, R.; Muzio, A.; Rena, O.; Baietto, G.; Parini, S.; Boldorini, R.; Giachino, D.; Papotti, M.; Scagliotti, G. V.; Migliore, E.; Mirabelli, D.; Moro, L.; Magnani, C.; Ferrante, D.; Matullo, G.; Dianzani, I. | |
| The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake | 1-gen-2022 | Gabano, E.; Zanellato, I.; Pinton, G.; Moro, L.; Ravera, M.; Osella, D. | |
| Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review | 1-gen-2021 | Pinton, Giulia; Manzotti, Beatrice; Balzano, Cecilia; Moro, Laura | |
| Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines | 1-gen-2021 | Gabano, E.; Pinton, G.; Balzano, C.; Boumya, S.; Osella, D.; Moro, L.; Ravera, M. | |
| CDKN2A determines mesothelioma cell fate to EZH2 inhibition | 1-gen-2021 | Pinton, Giulia; Wang, Zhuo; Balzano, Cecilia; Missaglia, Sara; Tavian, Daniela; Boldorini, Renzo; A Fennell, Dean; Griffin, Martin; Moro, Laura | |
| Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids | 1-gen-2021 | Mola, S.; Pinton, G.; Erreni, M.; Corazzari, M.; Andrea, M. D.; Grolla, A. A.; Martini, V.; Moro, L.; Porta, C. | |
| Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cells | 1-gen-2020 | Pinton, G.; Ferraro, A.; Balma, M.; Moro, L. | |
| Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells | 1-gen-2019 | Soluri, Angela Maria Felicia; Boccafoschi, Francesca; Cotella, Diego; Moro, Laura; Forestieri, Gabriela; Autiero, Ida; Cavallo, Luigi; Oliva, Romina; Griffin, Martin; Wang, Zhuo; Santoro, Claudio Ventura; Sblattero, Daniele | |
| A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings | 1-gen-2019 | Eskiocak, Ali Haydar; Missaglia, Sara; Moro, Laura; Durdu, Murat; Tavian, Daniela | |
| Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition | 1-gen-2019 | Ayinde, O.; Wang, Z.; Pinton, G.; Moro, L.; Griffin, M. | |
| Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality | 1-gen-2018 | Pinton, Giulia; Nilsson, Stefan; Moro, Laura | |
| Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency | 1-gen-2018 | Missaglia, Sara; Tavian, Daniela; Moro, Laura; Angelini, Corrado | |
| Clinical and genetic characterization of a Chanarin Dorfman Syndrome patient born to diseased parents | 1-gen-2018 | Durdu, M; Missaglia, S; Moro, L; Tavian, D | |
| Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia | 1-gen-2017 | Zonca, Sara; Pinton, Giulia; Wang, Z; Soluri, Mf; Tavian, D; Griffin, M; Sblattero, D; Moro, Laura | |
| Expression and therapeutic significance of estrogen receptor beta (ERβ) in malignant pleural mesothelioma | 1-gen-2017 | Pinton, Giulia; Moro, Laura | |
| Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement | 1-gen-2017 | Missaglia, Sara; Maggi, Lorenzo; Mora, Marina; Gibertini, Sara; Blasevich, Flavia; Agostoni, Piergiuseppe; Moro, Laura; Cassandrini, Denise; Santorelli, Filippo Maria; Gerevini, Simonetta; Tavian, Daniela | |
| SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells. | 1-gen-2016 | Pinton, Giulia; Zonca, Sara; Manente, Arcangela Gabriella; Cavaletto, Maria; Borroni, E; Daga, A; Jithesh, Pv; Fennell, D; Nilsson, S; Moro, Laura |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile